Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Zoetis Inc Class A (ZTS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 29,600,148
  • Shares Outstanding, K 490,800
  • Annual Sales, $ 4,888 M
  • Annual Income, $ 821,000 K
  • 36-Month Beta 1.02
  • Price/Sales 6.02
  • Price/Cash Flow 24.35
  • Price/Book 18.02

Price Performance

See More
Period Period Low Period High Performance
1-Month
54.59 +10.48%
on 04/24/17
60.88 -0.94%
on 05/22/17
+6.12 (+11.29%)
since 04/21/17
3-Month
52.25 +15.43%
on 04/06/17
60.88 -0.94%
on 05/22/17
+6.93 (+12.98%)
since 02/22/17
52-Week
45.28 +33.19%
on 06/27/16
60.88 -0.94%
on 05/22/17
+13.25 (+28.16%)
since 05/20/16

Most Recent Stories

More News
4 Large-Cap Drug Stocks To Buy Post Q1 Earnings

Take a look at these four large-cap drug stocks including Merck (MRK) that look well-positioned post Q1 earnings.

BAYRY : 131.2900 (+0.42%)
MRK : 64.04 (+0.41%)
ZTS : 60.31 (unch)
HLUYY : 51.9000 (+1.86%)
Zoetis Declares Third Quarter 2017 Dividend

The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a third quarter 2017 dividend payable to holders of the company's common stock of $0.105 per share. The dividend is to...

ZTS : 60.31 (unch)
Zoetis Holds Annual Meeting of Shareholders

Speaking to shareholders at the Zoetis Inc. (NYSE:ZTS) annual meeting today in Short Hills, N.J., Chief Executive Officer Juan Ramon Alaix discussed the company's 2016 performance...

ZTS : 60.31 (unch)
The New #218 Most Shorted S&P 500 Component: Zoetis

The most recent short interest data has been released for the 04/28/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the...

ZTS : 60.31 (unch)
Zoetis (ZTS) Beats Earnings, Revenue Estimates in Q1

Zoetis Inc. (ZTS) first-quarter 2017 earnings of 53 cents per share increased 10% year over year and surpassed the Zacks Consensus Estimate of 48 cents.

AGLE : 6.20 (-4.32%)
GALE : 0.56 (unch)
ZTS : 60.31 (unch)
INFI : 1.79 (+0.56%)
Zoetis (ZTS) Tops Earnings & Sales in Q1, Keeps 2017 View

Zoetis reported earnings of 53 cents per share beating the Zacks Consensus Estimate of 48 cents.

ZTS : 60.31 (unch)
Zoetis Announces First Quarter 2017 Results

--Reports Adjusted Net Income of $261 Million, or Adjusted Diluted EPS of $0.53, for First Quarter 2017

ZTS : 60.31 (unch)
Drug Stock Q1 Earnings Releases on May 4: ZTS, REGN & More

Here we have four pharma companies that are set to report first-quarter results on May 4. Let's see how things are shaping up for them.

JNJ : 127.26 (+0.20%)
MRK : 64.04 (+0.41%)
ZTS : 60.31 (unch)
INCY : 134.43 (+2.28%)
REGN : 460.99 (+2.44%)
ICPT : 113.72 (+1.29%)
PFE : 32.12 (-1.05%)
Zoetis to Participate in the Bank of America Merrill Lynch Health Care Conference

Zoetis Inc.(NYSE:ZTS) will participate in the Bank of America Merrill Lynch Health Care Conference on Wednesday, May 17, 2017, in Las Vegas, Nev. Juan Ramon Alaix, Chief Executive...

ZTS : 60.31 (unch)
What's in Store for Zoetis (ZTS) Stock This Earnings Season?

Zoetis Inc. (ZTS) is scheduled to report first-quarter 2017 results on May 4.

RARE : 57.38 (-0.16%)
ZTS : 60.31 (unch)
FGEN : 26.60 (-0.56%)
GILD : 64.36 (+0.20%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More

Business Summary

Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services.

See More

Support & Resistance

2nd Resistance Point 61.09
1st Resistance Point 60.70
Last Price 60.31
1st Support Level 60.10
2nd Support Level 59.89

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.